| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 7, 2026 | Grant(A) | 50K | — | $0 | 50K |
| Aug 7, 2026 | Disposed to issuer(D) | 6K | — | — | 0 |
| Aug 7, 2026 | Grant(A) | 6K | — | — | 6K |
| Aug 7, 2026 | Disposed to issuer(D) | 5K | — | — | 0 |
| Aug 7, 2026 | Grant(A) | 5K | — | — | 5K |
| Aug 7, 2026 | Disposed to issuer(D) | 131K | — | — | 0 |
| Aug 7, 2026 | Grant(A) | 131K | — | — | 131K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001692747-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for OnKure Therapeutics, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001692747-26-000004"
Use Arkolith to summarize insider buying and selling at OnKure Therapeutics, Inc. over the last 90 days and cite the filings.